Johanna Lempainen Selected Research

HLA-DR Antigens (HLA-DR)

11/2023	Increased Frequency of the HLA-DRB104:04-DQA103-DQB103:02 Haplotype Among HLA-DQB106:02-Positive Children With Type 1 Diabetes.
11/2020	HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
1/2020	Longitudinal Pattern of First-Phase Insulin Response Is Associated With Genetic Variants Outside the Class II HLA Region in Children With Multiple Autoantibodies.
1/2018	Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johanna Lempainen Research Topics

Disease

22	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 12/2010
10	Infections 02/2024 - 01/2019
9	COVID-19 02/2024 - 01/2021
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2017
2	Breakthrough Infections 02/2024 - 01/2022
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2023 - 10/2022
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023 - 01/2022
2	Reinfection 01/2023 - 01/2021
2	Insulinoma 01/2019 - 06/2013
1	Enterovirus Infections 10/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Coinfection 01/2022
1	Otitis Media 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 07/2020
1	Pharyngitis (Sore Throat) 01/2017

Drug/Important Bio-Agent (IBA)

16	AutoantibodiesIBA 05/2024 - 12/2010
8	Insulin (Novolin)FDA Link 05/2024 - 04/2012
8	VaccinesIBA 02/2024 - 01/2021
7	AntibodiesIBA 05/2024 - 01/2019
6	Neutralizing AntibodiesIBA 02/2024 - 01/2022
5	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 05/2024 - 06/2013
5	1,3-di(4-imidazolinophenoxyl)propaneIBA 11/2020 - 01/2017
4	HLA-DR Antigens (HLA-DR)IBA 11/2023 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2023 - 01/2022
4	mRNA VaccinesIBA 01/2023 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2020
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2015
3	Staphylococcal Protein A (Protein A)IBA 01/2022 - 01/2017
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 06/2013
3	BNT162 VaccineIBA 01/2022 - 01/2022
3	AntigensIBA 11/2020 - 06/2013
2	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023 - 12/2022
2	Immunoglobulin G (IgG)IBA 12/2022 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2020
1	HLA-DQB1 antigen (HLA DQB1)IBA 11/2023
1	HLA-DRB1*04 antigenIBA 11/2023
1	Coronavirus Spike GlycoproteinIBA 01/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	adenovirus receptorIBA 01/2023
1	SugarsIBA 01/2023
1	Amino Acids FDA Link 01/2023
1	HexosesIBA 01/2023
1	HLA-DQ Antigens (HLA-DQ)IBA 01/2023
1	LigandsIBA 01/2023
1	Quinic Acid (Quinate)IBA 01/2023
1	Threonine (L-Threonine)FDA Link 01/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	Poliovirus VaccinesIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 12/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Pattern Recognition ReceptorsIBA 10/2022
1	IFIH1 Interferon-Induced HelicaseIBA 10/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	CytokinesIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	NucleoproteinsIBA 01/2022
1	Interferon Type IIBA 01/2021
1	Zinc Transporter 8IBA 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	InterferonsIBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 01/2017

Therapy/Procedure

1	Personal Protective Equipment 01/2022